About Ildong Pharmaceutical
Ildong Pharmaceutical is a company based in Seoul (South Korea) founded in 1941 was acquired by H&Q Asia Pacific in July 2015.. The company has 1,060 employees as of December 31, 2024. Ildong Pharmaceutical operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
- Headquarter Seoul, South Korea
- Employees 1060 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ildong Pharmaceutical Co., Ltd.
-
Annual Revenue
$392.32 M (USD)-7.81as on Dec 31, 2025
-
Net Profit
$16.42 M (USD)0as on Dec 31, 2025
-
EBITDA
$25.34 M (USD)248.88as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
1060
as on Dec 31, 2024
-
Acquired by
H&Q Asia Pacific
(Jul 01, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ildong Pharmaceutical
Ildong Pharmaceutical is a publicly listed company on the KRX with ticker symbol 249420 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Ildong Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ildong Pharmaceutical
Ildong Pharmaceutical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include H&Q Asia Pacific. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Buyouts are targeted via private equity by H&Q Asia Pacific.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ildong Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ildong Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ildong Pharmaceutical Comparisons
Competitors of Ildong Pharmaceutical
Ildong Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| domain | founded_year | HQ Location |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ildong Pharmaceutical
Frequently Asked Questions about Ildong Pharmaceutical
When was Ildong Pharmaceutical founded?
Ildong Pharmaceutical was founded in 1941.
Where is Ildong Pharmaceutical located?
Ildong Pharmaceutical is headquartered in Seoul, South Korea.
Who is the current CEO of Ildong Pharmaceutical?
Yun Paul Woongsup is the current CEO of Ildong Pharmaceutical.
How many employees does Ildong Pharmaceutical have?
As of Dec 31, 2024, the latest employee count at Ildong Pharmaceutical is 1,060.
What is the annual revenue of Ildong Pharmaceutical?
Annual revenue of Ildong Pharmaceutical is $392.32M as on Dec 31, 2025.
What does Ildong Pharmaceutical do?
Ildong Pharmaceutical was founded in 1941 in Seoul, South Korea, and operates in the pharmaceutical sector. Active pharmaceutical ingredients, prescription and over-the-counter drugs, vitamins, probiotics, and antimicrobials are produced. Development efforts focus on treatments for resistant bacterial infections, malignant tumors, Alzheimers disease, obesity, and aging-related conditions. The portfolio extends to health foods, cosmetics, and medical devices, with ID12005A advancing in Phase 2 trials for Alzheimers.
Who are the top competitors of Ildong Pharmaceutical?
Ildong Pharmaceutical's top competitors include Merck, Roivant Sciences and Amgen.
Is Ildong Pharmaceutical publicly traded?
Yes, Ildong Pharmaceutical is publicly traded on KRX under the ticker symbol 249420.
Who are Ildong Pharmaceutical's investors?
Ildong Pharmaceutical has 1 investor. Key investors include H&Q Asia Pacific.
What is Ildong Pharmaceutical's ticker symbol?
The ticker symbol of Ildong Pharmaceutical is 249420 on KRX.